This article has Open Peer Review reports available.
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study
- Edward J. Gane1Email author,
- Edwin DeJesus2,
- Ewa Janczewska3,
- Jacob George4,
- Moises Diago5,
- Mariliza Hendrique Da Silva6,
- Henk Reesink7,
- Igor Nikitin8,
- Holger Hinrichsen9,
- Stefan Bourgeois10,
- Peter Ferenci11,
- Umesh Shukla12,
- Ronald Kalmeijer12,
- Oliver Lenz13,
- Bart Fevery13,
- Chris Corbett13,
- Maria Beumont13 and
- Wolfgang Jessner13
© The Author(s). 2017
Received: 12 January 2017
Accepted: 7 May 2017
Published: 2 June 2017
Open Peer Review reports
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|12 Jan 2017||Submitted||Original manuscript|
|30 Jan 2017||Reviewed||Reviewer Report - Marianne Martinello|
|5 Feb 2017||Reviewed||Reviewer Report - Behzad Hajarizadeh|
|4 Apr 2017||Author responded||Author comments - Edward J Gane|
|Resubmission - Version 2|
|4 Apr 2017||Submitted||Manuscript version 2|
|4 May 2017||Author responded||Author comments - Edward J Gane|
|Resubmission - Version 3|
|4 May 2017||Submitted||Manuscript version 3|
|7 May 2017||Editorially accepted|
|2 Jun 2017||Article published||10.1186/s12879-017-2444-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.